Case Commentary On Sun Pharmaceutical Industries Ltd. V. Cipla Ltd




Case Commentary On Sun Pharmaceutical Industries Ltd. V. Cipla Ltd., Appl. Nos. 1980, 1982 & 1983 Of 2021


Pratyus Sarangi, Bennett University


Introduction


In the case of Sun Pharmaceutical Industries Ltd. v. Cipla Ltd., two major pharmaceutical giants of India, i.e., Sun Pharma and Cipla locked horns over a trademark dispute. This case was a classic modernistic development in the domain of trademark infringement, which came in the backdrop of COVID-19 outbreak. This case analyses the opportunistic approach of putting forward socio-legal contentions in order to get away with legal obligations.


The instant matter includes a dispute where Sun Pharma, the applicant/defendant, has allegedly infringed the registered trademark of the respondent/plaintiff, i.e., Cipla Ltd., by manufacturing and selling deceptively similar drugs in the backdrop of pandemic, when the entire country was facing extraordinary demands of related drugs and the supply of such drugs were scarce.

Indian Journal of Law and Legal Research

Abbreviation: IJLLR

ISSN: 2582-8878

Website: www.ijllr.com

Accessibility: Open Access

License: Creative Commons 4.0

Submit Manuscript: Click here

Open Access Logo

Licensing:

​All research articles published in The Indian Journal of Law and Legal Research are fully open access. i.e. immediately freely available to read, download and share. Articles are published under the terms of a Creative Commons license which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Disclaimer:

The opinions expressed in this publication are those of the authors. They do not purport to reflect the opinions or views of the IJLLR or its members. The designations employed in this publication and the presentation of material therein do not imply the expression of any opinion whatsoever on the part of the IJLLR.